These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29337217)

  • 1. Peptide drug stability: The anti-inflammatory drugs Pep19-2.5 and Pep19-4LF in cream formulation.
    Kuhlmann N; Heinbockel L; Correa W; Gutsmann T; Goldmann T; Englisch U; Brandenburg K
    Eur J Pharm Sci; 2018 Mar; 115():240-247. PubMed ID: 29337217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicological and Safety Pharmacological Profiling of the Anti-Infective and Anti-Inflammatory Peptide Pep19-2.5.
    Möller C; Heinbockel L; Garidel P; Gutsmann T; Mauss K; Weindl G; Fukuoka S; Loser D; Danker T; Brandenburg K
    Microorganisms; 2022 Dec; 10(12):. PubMed ID: 36557665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial peptides Pep19-2.5 and Pep19-4LF inhibit Streptococcus mutans growth and biofilm formation.
    Jannadi H; Correa W; Zhang Z; Brandenburg K; Oueslati R; Rouabhia M
    Microb Pathog; 2019 Aug; 133():103546. PubMed ID: 31112769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic antimicrobial and LPS-neutralising peptides suppress inflammatory and immune responses in skin cells and promote keratinocyte migration.
    Pfalzgraff A; Heinbockel L; Su Q; Gutsmann T; Brandenburg K; Weindl G
    Sci Rep; 2016 Aug; 6():31577. PubMed ID: 27509895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Lipopolysaccharide- and Lipoprotein-Induced Inflammation by Antitoxin Peptide Pep19-2.5.
    Heinbockel L; Weindl G; Martinez-de-Tejada G; Correa W; Sanchez-Gomez S; Bárcena-Varela S; Goldmann T; Garidel P; Gutsmann T; Brandenburg K
    Front Immunol; 2018; 9():1704. PubMed ID: 30093904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation and release of As pidasept peptides in polysaccharide formulation for oral application.
    Kuhlmann N; Nehls C; Heinbockel L; Correa W; Moll R; Gutsmann T; Hübner C; Englisch U; Brandenburg K
    Eur J Pharm Sci; 2021 Mar; 158():105687. PubMed ID: 33359480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutical Administration of Peptide Pep19-2.5 and Ibuprofen Reduces Inflammation and Prevents Lethal Sepsis.
    Heinbockel L; Marwitz S; Barcena Varela S; Ferrer-Espada R; Reiling N; Goldmann T; Gutsmann T; Mier W; Schürholz T; Drömann D; Brandenburg K; Martinez de Tejada G
    PLoS One; 2015; 10(7):e0133291. PubMed ID: 26197109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Synthetic, Host-defense Peptide Protects Against Organ Injury/Dysfunction in a Rat Model of Severe Hemorrhagic Shock.
    Yamada N; Martin LB; Zechendorf E; Purvis GSD; Chiazza F; Varrone B; Collino M; Shepherd J; Heinbockel L; Gutsmann T; Correa W; Brandenburg K; Marx G; Schuerholz T; Brohi K; Thiemermann C
    Ann Surg; 2018 Aug; 268(2):348-356. PubMed ID: 28288070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Infective and Anti-Inflammatory Mode of Action of Peptide 19-2.5.
    Heinbockel L; Weindl G; Correa W; Brandenburg J; Reiling N; Wiesmüller KH; Schürholz T; Gutsmann T; Martinez de Tejada G; Mauss K; Brandenburg K
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Early Application of Synthetic Peptides 19-2.5 and 19-4LF to Improve Survival and Neurological Outcome in a Mouse Model of Cardiac Arrest and Resuscitation.
    Bajorat R; Danckert L; Ebert F; Bancken T; Bergt S; Klawitter F; Vollmar B; Reuter DA; Schürholz T; Ehler J
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a nose cream containing the synthetic antimicrobial peptide P60.4Ac for eradication of methicillin-resistant Staphylococcus aureus carriage.
    Göblyös A; Schimmel KJ; Valentijn AR; Fathers LM; Cordfunke RA; Chan HL; Oostendorp J; Nibbering PH; Drijfhout JW; Hiemstra PS; Hartigh JD
    J Pharm Sci; 2013 Oct; 102(10):3539-44. PubMed ID: 23955373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane-bound and free toxins.
    Correa W; Heinbockel L; Behrends J; Kaconis Y; Barcena-Varela S; Gutsmann T; Mauss K; Schürholz T; Schromm AB; Martinez de Tejada G; Brandenburg K
    FEBS J; 2019 Apr; 286(8):1576-1593. PubMed ID: 30843356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial endotoxin-neutralizing peptides promote keratinocyte migration via P2X7 receptor activation and accelerate wound healing in vivo.
    Pfalzgraff A; Bárcena-Varela S; Heinbockel L; Gutsmann T; Brandenburg K; Martinez-de-Tejada G; Weindl G
    Br J Pharmacol; 2018 Sep; 175(17):3581-3593. PubMed ID: 29947028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometric Quantification of the Antimicrobial Peptide Pep19-2.5 with Stable Isotope Labeling and Acidic Hydrolysis.
    Wohlfart S; Kilian M; Storck P; Gutsmann T; Brandenburg K; Mier W
    Pharmaceutics; 2021 Aug; 13(9):. PubMed ID: 34575418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty Acid Conjugation Leads to Length-Dependent Antimicrobial Activity of a Synthetic Antibacterial Peptide (Pep19-4LF).
    Storck P; Umstätter F; Wohlfart S; Domhan C; Kleist C; Werner J; Brandenburg K; Zimmermann S; Haberkorn U; Mier W; Uhl P
    Antibiotics (Basel); 2020 Nov; 9(12):. PubMed ID: 33255900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of a Topical Anti-Inflammatory Preparation Containing Dodonaea polyandra Extract.
    Simpson BS; Luo X; Wang J; Song Y; Claudie D; Garg S; Smith N; McKinnon R; Semple S
    J Pharm Pharm Sci; 2015; 18(4):578-99. PubMed ID: 26626250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic Anti-lipopolysaccharide Peptides (SALPs) as Effective Inhibitors of Pathogen-Associated Molecular Patterns (PAMPs).
    Correa W; Heinbockel L; Martinez-de-Tejada G; Sánchez S; Garidel P; Schürholz T; Mier W; Dupont A; Hornef M; Gutsmann T; Mauss K; Weindl G; Brandenburg K
    Adv Exp Med Biol; 2019; 1117():111-129. PubMed ID: 30980356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pep19 drives epitope spreading in periodontitis and periodontitis-associated autoimmune diseases.
    Kwon EY; Cha GS; Jeong E; Lee JY; Kim SJ; Surh CD; Choi J
    J Periodontal Res; 2016 Jun; 51(3):381-94. PubMed ID: 26362417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supramolecular structure of enterobacterial wild-type lipopolysaccharides (LPS), fractions thereof, and their neutralization by Pep19-2.5.
    Brandenburg K; Heinbockel L; Correa W; Fukuoka S; Gutsmann T; Zähringer U; Koch MH
    J Struct Biol; 2016 Apr; 194(1):68-77. PubMed ID: 26828112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of methylparaben, propylparaben, triamcinolone acetonide and its degradation product in a topical cream by RP-HPLC.
    Matysová L; Hájková R; Sícha J; Solich P
    Anal Bioanal Chem; 2003 Jun; 376(4):440-3. PubMed ID: 12819846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.